What were our readers looking at over the previous month? These were the ten most clicked stories on our website from 10 July-11 August: Health and disability are not mutually …

As part of its Deprescribing Action Week, SHPA will be running a webinar on Wednesday 16 August  The MedsAware webinar will provide an overview of deprescribing, including reference to deprescribing …

Raising awareness on deprescribing as SHPA launches MedsAware Week, featuring a webinar Next week is #MedsAware 2023, SHPA’s Deprescribing Action Week raising awareness around polypharmacy and deprescribing. SHPA President Tom …

We’re endeavouring to identify the leading heroes of pharmacy in 2023 and we’re inviting you to make your nominations During Covid and other recent natural disasters and, most recently, throughout …

Politicians turn out in NSW to declare their support for community pharmacy  The Pharmacy Guild of NSW welcomed a stellar cast of the state’s political and bureaucratic health leaders to …

As the countdown nears to the 1 September D-Day, attention in pharmacy continues to centre around 60-day dispensing The week began with Opposition Health spokesperson Senator Anne Ruston warning again …

Regulator calls for public consultation on criminal history standard for registered health practitioners  Australia’s health practitioner regulator is inviting the public to contribute towards its review of the national standard …

Lisa Nguyen stepped into uncharted territory when she founded Australia’s first cannabis-specialised dispensary. She talks about what drew her to specialise in this area, and the hot topics It’s one …

SHPA President Tom Simpson talks about the organisation’s new Transformation agenda for pharmacy This week SHPA released Transformation 2024, a ‘growth agenda over the next twelve months to expand the …

TGA says it will clamp down on vapes, medicinal cannabis and the wellness industry over the next 12 months The Therapeutic Goods Administration (TGA) has published its import, advertising and supply …

Naloxone, hazardous use of alcohol and treatment inequity: part two of our expert discussion of the latest in harm minimisation Why is the naloxone program not seeing wider take-up? Should …

We look at some of the recent changes to the medicines landscape, with new products, new indications, safety related changes and more New Products Finerenone (Kerendia) is a nonsteroidal antagonist …